MedTrace Logo

Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women

NCT03365466 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-12-07

No results posted yet for this study

Summary

The aim of the study is to investigate whether Low Dose Aspirin and Low Molecular Weight Heparin could increase the uterine perfusion, and finally improve the implantation and pregnancy rates in patients with unexplained recurrent implantation failure.

Conditions

  • Recurrent Implantation Failure

Interventions

DRUG

Low dose aspirin

LDA 25mg tid

DRUG

Low molecular weight heparin

LMWH 5000u IH qd

DRUG

Low dose aspirin plus low molecular weight heparin

LDA 25mg tid + LMWH 5000u IH qd

DRUG

no treatment

Patients who did not receive any treatment.

Sponsors & Collaborators

  • Shanghai First Maternity and Infant Hospital

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2018-12-31
Completion
2019-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365466 on ClinicalTrials.gov